Skip to main content
SpringerLink
Log in

The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Aims of the study were: 1. to establish the prevalence of CD44 protein expression in human astrocytomas; 2. to compare the distribution of the extracellular matrix in these tumors; 3. to investigate the relation between CD 44, the extracellular matrix proteins and the histological grade of the tumor. CD44, Type IV Collagen (Col IV), Laminin (LN), Fibronectin (FN), and Tenascin (TN) expression were detected by immunohistochemistry in formalin fixed paraffin embedded tissue samples of 52 astrocytic tumors: 35 glioblastomas (GB), 7 Anaplastic astrocytomas (AA) and 10 astrocytomas (A). The localization of Col IV was observed in the basement membrane of the vessel walls in most of the astrocytomas (88.4%) with a similar pattern obtained with LN staining. 7 of 10 A (70%), 2 of 7 AA (28%) and 9 of 35 GB (25.7%) showed LN positivity. There was a negative correlation between LN expression and tumor grade (p=0.03). FN was either localized in the basement membrane or showed thick multi-layered immunoreactivity of the vessel walls. FN expression was seen in 6 A (60%), 4 AA (57%) and all of 35 GB (100%). The FN distribution was not uniform and its staining intensity showed decrease in GB. 3A (30%), 3 AA (42%), 27 GB (77.1%) showed TN expression in the vessel walls and in some tumor cells of 19 GBs. TN expression was positively correlated with the degree of vascular endothelial proliferation in GB (p<0.05). The expression of CD44s was seen as plasma membrane positivity of glioma cells in 5 of 10A (50%), 3 of 7AA (42.3%) and 29 of 35 GB (82.8%). The intensity of immunoreaction was quite strong especially near the vessels. There was a good correlation between TN and CD44s expression in human astrocytic tumors (p=0.005). No relationship was observed between GFAP, ECM proteins and CD44s expression. Both CD44s and TN expression showed increase with malignancy in astrocytomas. These findings indicated that the histological malignancy of the astrocytomas was correlated with expression of TN and CD44s. It was suggested that in astrocytomas there was a biological relationship only between CD44 and TN, but none with the other ECM proteins. TN may play a role in angiogenesis in human astrocytic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ariza A, Lopez D, Mate JL et al Role of CD44 in Invasiveness of Glioblastoma Multiforme and the Noninvasivness of Meningioma. Hum Pathol 26:1144–1147, 1995.

    Article  PubMed  CAS  Google Scholar 

  2. Attanoos RL, Webb R, Gibss AR: CD44H Expression in Reactive Mesothelium, Pleural Mesothelioma and Pulmonary Adenocarcinoma. Histopathol 30:260–263, 1997.

    Article  CAS  Google Scholar 

  3. Bellon G, Caulet T, Cam T, et al: Immunohistochemical Localization of Macromolecules of the Basement Membrane and Extracellular Matrix of Human Gliomas and Meningiomas. Acta Neuropathol (Berl) 66:245–252, 1985.

    Article  CAS  Google Scholar 

  4. Brodkey JA, Laywell FD, O’Brien TF, et al Focal Brain Injury and Upregulation of a Developmentally Regulated Extracellular Matrix Protein. J Neurosurg 82:106 112, 1995.

    PubMed  Google Scholar 

  5. Broll R, Meyer S, Neubner M, et al: Expression of Tenascin in Tumors of the Esophagus, Small Intestine and Colorectum. Gen Diagn Pathol 141:111–119, 1995.

    PubMed  CAS  Google Scholar 

  6. Burger PC, Scheithauer BW: Tumors of Neuroglia and Choroid Plexus Epithelium. Ed. Tumor of the Central Nervous System. Atlas of Tumor Pathology. Armed Forces Institute of Pathology. Washington D.C. Bethesta, Maryland, 1994 p: 25–68.

    Google Scholar 

  7. Chiquet-Ehrismann R, Kalla P, Pearson CA, et al: Tenascin Interferes with Fibronectin Action. Cell 53:383–390, 1988.

    Article  PubMed  CAS  Google Scholar 

  8. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, et al Tenascin: An Extracellular Matrix Protein Involved in Tissue Interactions during Fetal Development and Oncogenesis. Cell 47:131–139, 1986.

    Article  PubMed  CAS  Google Scholar 

  9. Darai E, Walker-Combrouze F, Fauconnier A, et al: Analysis of CD44 Expression in Serous and Mucinous Borderline Tumors of the Ovary: Comparision with Cystadenomas and Overt Carcinomas. Histopathol 32:151–159, 1998.

    Article  CAS  Google Scholar 

  10. Faissner A, Scholze A, Gotz B:Tenascin Glycoproteins in Developing Neural Tissues: Only Decoration? Perspect Dev Neurobiol 2:53–66, 1994.

    PubMed  CAS  Google Scholar 

  11. Fasana M, Sabatini MT, Wieczorek R, et al: CD44 and Its v6 Spliced Variant in Lung Tumors. Cancer 80:34–41, 1997.

    Article  Google Scholar 

  12. Fox SB, Fawcett J, Jackson DG, et al: Normal Human Tissues, in Addition to some Tumors, Express Multiple Different CD44 Isoforms. Cancer Res 54:4539–4546, 1994.

    PubMed  CAS  Google Scholar 

  13. Fox SB, Gatter KC, Jackson DG, et al: CD44 and Cancer Screening (letters to the Editor) Lancet 342:548–549, 1993.

    Article  PubMed  CAS  Google Scholar 

  14. Girgrah N, Letarte M, Becker LE, et al: Localization of the Cd44 Glycoprotein to Fibrous Astrocytes in Normal White Matter and to Reactive Astrocytes in Active Lesions in Multiple Sclerosis. J Neuropathol Exp Neurol 50:779–792, 1991.

    Article  PubMed  CAS  Google Scholar 

  15. Glese A, Rief MD, Loo MA, et al: Determination of Human Astrocytoma Migration. Cancer Res 54:3897–3904, 1994.

    Google Scholar 

  16. Hankard GF, Cezard JP, Aigram Y, et al: CD44 Variam Expression in Inflammatory Colonic Mucosa is not Disease Specific but Associated with Increased with Crypt Cell Proliferation. Histopathol 32:317–321, 1998.

    Article  Google Scholar 

  17. Higuchi M, Ohnishi N, Arita S, et al: Expression of Tenascin in Human Gliomas: Its relation to Histologic Malignancy, Tumor Dedifferentiation and Angiogenesis. Acta Neuropathol 85:481–487, 1993.

    Article  PubMed  CAS  Google Scholar 

  18. Howeedy AA, Virtanen I, Laitinen L, et al: DifFerential Distribution of Tenascin in Normal, Hyperplastic and Neoplastic Breast. Lab Invest 63:798–806, 1990.

    PubMed  CAS  Google Scholar 

  19. Iczkowski KA, Shanks JH, Bostwick DG: Loss of CD44 Variant 6 Expression Differentiates Small Cell Carcinoma of Urinary Bladder from Urothelial (transitional cell) Carcinomas. Histopathol 32:322–327, 1998.

    Article  CAS  Google Scholar 

  20. Ingle J, Jennings TA, Goodman ML, et al: CD44 Expression in Sinonasal Inverted Papillomas and Associated Squamous Cell Carcinoma. Am J Clin Pathol 109:309–314, 1998.

    PubMed  CAS  Google Scholar 

  21. Khoshyomn S, Penar PL, Wadsworth MP, et al: Localization of Cd44 at the Invasive Margin of Glioblastomas by Immunelectron Microscopy. Ultrastruct Pathol 21:517–425, 1997.

    Article  PubMed  CAS  Google Scholar 

  22. Kleihues P, Burger PC, Scheithauer BW: Histological typing of Tumors of the Central Nervous System.World Health Organisation. Berlin, Springer-Verlag, 1993.

    Google Scholar 

  23. Koukoulis GK, Gould VE, Bhattacharyya A, et al: Tenascin in Normal, Reactive, Hyperplastic and Neoplastic Tissues. Hum Pathol 22:636–643, 1997.

    Article  Google Scholar 

  24. Kupper MC, Van-Meir E, Gaultier L, et al: Differential Expression of the CD44 Molecule in Human Brain Tumors. Int J Cancer 50:572–577, 1992.

    Article  Google Scholar 

  25. Lagorge-Pages C, Paraf F, Dubuis S, et al: Expression of CD44 In Premalignant and Malignant Barret’s Oesephagus. Histopathol 37:7–14, 1998.

    Article  Google Scholar 

  26. Lesley J, Hyman R, Kincade PW: Cd44 and its Interaction with Extracellular Matrix. Adv Immunol 54:271–335, 1993.

    Article  PubMed  CAS  Google Scholar 

  27. Li H, Hamou MF, Lribolet N, et al: Variant CD44 Adhesion Molecules are Expressed in Human Brain Metastases but not in Glioblastomas. Cancer Res 53:5345–5349, 1993.

    PubMed  CAS  Google Scholar 

  28. Mackie EJ, Halfter W, Liverani D: Induction of Tenascin in Healing Wounds. J Cell Biol 107:2757–2767, 1988.

    Article  PubMed  CAS  Google Scholar 

  29. Maenpa A, Kovanen PE, Paetau A, et al: Lymphocyte Adhesion Molecule Ligands and Extracellular Matrix Proteins in Gliomas and Normal Brain: Expression of VCAM-1 in Gliomas. Acta Neuropathol (Berl) 94:216–225, 1997.

    Article  Google Scholar 

  30. Mahesparan R, Tysnes BB, Edvardsen K, et al: Role of High Molecular Weight Extracellular Matrix Proteins in Glioma cell Migration. Neuropath Appl Neurobiol 23:102–112, 1997.

    Article  CAS  Google Scholar 

  31. Merzak A, Koochekpour S, Pilkington GJ: Adhesion of Glioma Cells to Fibronectin, Laminin, Vitronectin and Collagen I is Modulated by Gangliosides in vitro. Cell Adhes Commun 3:27–43, 1995.

    Article  PubMed  CAS  Google Scholar 

  32. Natali PG, Zardi L: Tenascin: a Hexameric Adhesive Glycoprotein. Int J Cancer Suppl 4:66–68, 1989.

    Article  PubMed  CAS  Google Scholar 

  33. Penno MB, August JT, Baylin SB, et al: Expression of CD44 in Human Lung Tumors. Cancer Res 54:1381–1387, 1994.

    PubMed  CAS  Google Scholar 

  34. Russell DS, Rubinstein LJ: Tumors of Central Neuro-epithelial Origin: In pathology of Tumours of the Nervous System. 5. Ed. Edward Arnould, London, 1989 pp:83–350.

    Google Scholar 

  35. Ventimiglia JB, Wikstrand CJ Ostrowski LE, et al: Tenascin Expression in Human Glioma Cell Lines and Normal Tissue. J Neuroimmunol 36:41–55, 1992.

    Article  PubMed  CAS  Google Scholar 

  36. Yamamoto H, Ohnisi T, Arita N, et al: Migration and Adhesivnes of Malignant Glioma Cells to Fibronectin or Vitronectin and Their Expression of Integrin Subunits. Nippon Rinsho 53:1683–1687, 1995.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Istanbul University, Cerrahpa∘a Medical Faculty, Turkey

    Büge Öz, Ferah Anik Karayel & Kerem Balci

  2. Department of Neurosurgery, Istanbul University, Cerrahpa∘a Medical Faculty, Istanbul, Turkey

    Nurperi Gaziođlu & Fatma Özlen

Authors
  1. Büge Öz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ferah Anik Karayel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nurperi Gaziođlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fatma Özlen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kerem Balci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Büge Öz.

Additional information

This study was presented in part of the XXIInd International Congress of the International Academy of Pathology. October 18–23 1998, Nice-France. This study was supported by the Research Fund of the University of Istanbul. Project number: B-34/150998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Öz, B., Karayel, F.A., Gaziođlu, N. et al. The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol. Oncol. Res. 6, 118–124 (2000). https://doi.org/10.1007/BF03032361

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032361

Keywords

Search

Navigation